Empagliflozin vs Pravastatin
Empagliflozin vs Pravastatin: Overview
This comparison examines the pharmacological differences between Empagliflozin and Pravastatin.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Pravastatin: Competitive inhibitor of HMG-CoA reductase.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Pravastatin β 1.8 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Pravastatin β C23H36O7.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Pravastatin β 424.5280 g/mol.
Type: Empagliflozin β Small molecule; Pravastatin β Small molecule.